Contrarian
Scion Asset Management: 13F holdings
2025 Q3 filing (holdings as of 2025-09-30) · SEC 13F, published within 45 days of quarter end
- $1.4BReported AUM
- +138.8%vs last quarter
- 8holdings
- 100.0%top-10 concentration
Top holdings
| Stock | Weight | Share change |
|---|---|---|
| PLTR Palantir New | 66.04% | — |
| NVDA NVIDIA New | 13.51% | — |
| PFE Pfizer New | 11.07% | — |
| HAL Halliburton New | 4.45% | — |
| MOH Molina Healthcare New | 1.73% | — |
| LULU Lululemon | 1.29% | -83.4% |
| SLM SLM New | 0.96% | — |
| BRKR Bruker New | 0.95% | — |
Notable changes this quarter
| New position | Palantir | $912M |
| New position | NVIDIA | $187M |
| Sold out | UnitedHealth | $-115M |
| Sold out | Regeneron Pharmaceuticals | $-113M |
| Trimmed | Lululemon | $-89M |
Other funds
See all whale moves in the app
Fund holdings and insider and congressional filings, all in the app's whale tracker.
13F covers long positions in US-listed securities only, excluding shorts, cash and non-US assets. For information only; not investment advice.